Gastro-Oesophageal Reflux Disease (2011)
- NETI - Workshop Program
- Clinical Information
- Hepatitis C Information
- GESA Membership
- GESA Research
- Grants and Fellowships
- Australian Gastroenterology Week (AGW)
- GESA Colonoscopy Recertification Program
- NETI - National Endoscopy Training Initiative
- GUT School
- Useful Links
- Optimal Cancer Care Pathways
- Surveillance Colonoscopy Guidelines
- National Bowel Cancer Screening Program
Gastro-oesophageal reflux disease (GORD) occurs when reflux exposes the patient to the risk of physical complications or symptoms leading to a significant impairment of well-being or quality of life. Reflux disease is common. Between 15- 20% of adults experience heartburn at least once a week.
The fifth edition (2011) alerts health professionals to recent information published on Gastro-Oesophageal Reflux Disease (GORD).
It is intended to be used as a guide only and not as an authorative statement of every conceivable step or circumstance which may or could relate to the management of GORD.
Specific recommendations are based on relevant published information and will be updated periodically as new information becomes available. This information is due to be revised in 2013/2014.
This Clinical Update was compiled and written by the The Digestive Health Foundation (DHF), and sponsored by the Gastroenterological Society of Australia.
Download GESA Clinical Update:Gastro-Oesophageal Reflux Disease